Evidence map›Paper›PMID 41741719›Full record

ArticleArchives of virology2026

Length and density of α2-3 sialyllactose-containing chains on glycopolymers determine receptor binding of avian influenza viruses.

Daiki Kobayashi, Takahiro Hiono, Ryota Adachi, Manabu Igarashi, Takahiko Matsushita, Norikazu Isoda, Yoshihiro Sakoda, Koji Matsuoka

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daiki KobayashiLaboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-Ku, Sapporo, Hokkaido, 060-0818, Japan.ORCID http://orcid.org/0009-0007-0072-1042
Takahiro HionoLaboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-Ku, Sapporo, Hokkaido, 060-0818, Japan. hiono@vetmed.hokudai.ac.jp.ORCID http://orcid.org/0000-0001-8897-3592
Ryota AdachiArea for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, 225 Shimo-Ohkubo, Sakura-Ku, Saitama, Saitama, 338-8570, Japan.
Manabu IgarashiInternational Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido, 001-0020, Japan.
Takahiko MatsushitaArea for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, 225 Shimo-Ohkubo, Sakura-Ku, Saitama, Saitama, 338-8570, Japan.
Norikazu IsodaLaboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-Ku, Sapporo, Hokkaido, 060-0818, Japan.
Yoshihiro SakodaLaboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Kita 18, Nishi 9, Kita-Ku, Sapporo, Hokkaido, 060-0818, Japan.
Koji MatsuokaArea for Molecular Function, Division of Material Science, Graduate School of Science and Engineering, Saitama University, 225 Shimo-Ohkubo, Sakura-Ku, Saitama, Saitama, 338-8570, Japan.

Funding

Japan Agency for Medical Research and Development JP253fa627005Japan International Cooperation Agency JP23jm0110019Japan Science and Technology Agency JPMJSP2119Japan Society for the Promotion of Science 22KK0094Japan Society for the Promotion of Science 23KJ0059Japan Society for the Promotion of Science 24K09260Ministry of Education, Culture, Sports, Science and Technology 1801
6 · The paper itself

Abstract

Influenza A viruses use host sialoglycans for attachment via hemagglutinin (HA) and hydrolyze them upon budding via neuraminidase (NA). The HAs of some human isolates prefer extended and branched glycans for binding; however, the preference of avian influenza viruses (AIVs) for these glycans is poorly understood. This study addressed the glycan-binding preferences of HA and AIV particles by using a series of sialoglycopolymers with various glycan representations and densities. Glycan extension was mimicked by linking the terminal sialyllactose with subsequent polyethylene glycol chains, and glycan density was further controlled by polymerizing the glycomonomers with the corresponding numbers of acrylamide spacers. Recombinant HAs and particles of two AIVs were used in a solid-phase direct binding assay with the aforementioned sialoglycopolymers. Both recombinant HAs preferred higher-density glycans, but did not bind to the homopolymer with the highest density. These observations suggested that most sialyllactoses in the highest-density polymer were not involved in the interaction with HA, whereas extremely high-density sialyllactoses negatively impacted HA binding. Additionally, binding analysis using viral particles demonstrated that HA clusters on the particles compensated for weak binding to low-density glycans by employing multivalent HA-glycan interactions. This approach enabled the evaluation of the complex nature of viral particles as macromolecules in glycan binding and the clustering effect of glycan density in a glycopolymer. These findings suggest elaborate protein-carbohydrate interactions via multivalent receptor-ligand binding between AIV particles and sialoglycans.

Indexed as

Hemagglutinin Glycoproteins, Influenza VirusInfluenza A virusInfluenza in BirdsLactoseOligosaccharidesPolysaccharidesReceptors, VirusVirus AttachmentAnimalsHumansNeuraminidaseProtein Binding3'-sialyllactoseHemagglutinin Glycoproteins, Influenza VirusLactoseNeuraminidaseOligosaccharidesPolysaccharidesReceptors, Virus

Identifiers

PMID41741719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.